Inventor · disambiguated record
Evan Lewis
Also filed as: LEWIS EVAN · LEWIS EVAN R
8 granted patents·5 pending applications·146 citations·filing 2001–2022
85Inventor score
Top patents by PatentIndex Score
13 records- 0193US7737112B2Composition for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2005·Granted Jun 15, 2010·87 cites·32 claims
- 0291US7425541B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2001·Granted Sep 16, 2008·37 cites·23 claims
- 0390US8034787B2Enzyme-cleavable prodrug compoundsMEDAREX INC·Filed 2008·Granted Oct 11, 2011·8 cites·17 claims
- 0488US10159746B2Cyclodextrin complexation methods for formulating peptide proteasome inhibitorsONYX THERAPEUTICS INC·Filed 2013·Granted Dec 25, 2018·14 cites·30 claims
- 0579US11891383B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2022·Granted Feb 6, 2024·0 cites·18 claims
- 0669US11479548B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2020·Granted Oct 25, 2022·0 cites·9 claims
- 0765US10836756B2Crystalline salts of peptide epoxyketone immunoproteasome inhibitorKEZAR LIFE SCIENCES·Filed 2017·Granted Nov 17, 2020·0 cites·20 claims
- 0863US12357638B2Immunoproteasome inhibitor formulationsKEZAR LIFE SCIENCES·Filed 2019·Granted Jul 15, 2025·0 cites·16 claims
- 0959US2009215093A1Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2009·Application pending·0 cites
- 1050US2006088471A1Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2005·Application pending·0 cites
- 1141US2013303482A1Cylodextrin Complexation Methods for Formulating Peptide Proteasome InhibitorsLEWIS EVAN·Filed 2012·Application pending·0 cites
- 1241US2013303465A1Cylodextrin Complexation Methods for Formulating Peptide Proteasome InhibitorsLEWIS EVAN·Filed 2012·Application pending·0 cites
- 1340US2004132830A1Triphenylmethane kinesin inhibitorsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →